Efficacy of zoledronate, denosumab or teriparatide in postmenopausal women with type 2 diabetes mellitus at high risk of fragility fractures: protocol of an open, blinded endpoint randomized controlled pilot trial

BACKGROUND: People with type 2 diabetes (T2D) are at high risk of fragility fractures; however, there are no randomized controlled trials evaluating the efficacy of anti-osteoporosis drugs as a primary pre-specified endpoint in T2D. OBJECTIVES: To compare the efficacy of anti-osteoporotic drugs in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Prasad, Trupti Nagendra, Bhadada, Sanjay Kumar, Singla, Veenu, Aggarwal, Neelam, Ram, Sant, Saini, Uttam Chand, Kumar, Ashok, Pal, Rimesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590540/
https://www.ncbi.nlm.nih.gov/pubmed/37873516
http://dx.doi.org/10.1177/20420188231207516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590540/
https://www.ncbi.nlm.nih.gov/pubmed/37873516
http://dx.doi.org/10.1177/20420188231207516

Ejemplares similares